Introduction and Objectives Left ventricular hypertrophy (LVH)
is a significant risk factor of cardiovascular disease and is associated with increased mortality. Previous studies have shown an increased prevalence of LVH in normoxaemic COPD patients. The impact of LVH on mortality in COPD is yet to be established.
We evaluated the impact of LVH on mortality in COPD patients by measurement of left ventricular dimensions by echocardiography.
Methods
We performed a retrospective cohort study utilising a NHS database of COPD patients (TARDIS) (7) 68 (8) 67 (7) 67 ( 
